Cargando…

β-Blocker Use and Cardiovascular Outcomes in Hemodialysis: A Systematic Review

RATIONALE & OBJECTIVE: There is conflicting evidence regarding the type of β-blockers to use in dialysis patients. This systematic review seeks to determine whether highly dialyzable β-blockers are associated with higher rates of cardiovascular events and mortality in hemodialysis patients than...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tella, Abhinav, Vang, William, Ikeri, Eustacia, Taylor, Olivia, Zhang, Alicia, Mazanec, Megan, Raju, Srihari, Ishani, Areef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9079357/ https://www.ncbi.nlm.nih.gov/pubmed/35539430 http://dx.doi.org/10.1016/j.xkme.2022.100460

Ejemplares similares

Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis
por: Wetmore, James B., et al.
Publicado: (2016)

β-blockers in hemodialysis: simple questions, complicated answers
por: Hundemer, Gregory L, et al.
Publicado: (2020)

Should We Use Dialyzable β-Blockers in Hemodialysis?
por: Georgianos, Panagiotis I., et al.
Publicado: (2022)

Agreement of reported vascular access on the medical evidence report and on medicare claims at hemodialysis initiation
por: Solid, Craig A, et al.
Publicado: (2014)

Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis
por: Kang, Seok-Hui, et al.
Publicado: (2023)

Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers
por: Lin, Yi-Ting, et al.
Publicado: (2021)

Effect of Nurse Case Management Compared With Usual Care on Controlling Cardiovascular Risk Factors in Patients With Diabetes: A randomized controlled trial
por: Ishani, Areef, et al.
Publicado: (2011)

2323 Large patient volume is associated with adverse patient outcomes among those requiring maintenance renal replacement therapy
por: Reule, Scott, et al.
Publicado: (2018)

The Real Role of β-Blockers in Daily Cardiovascular Therapy
por: Dézsi, Csaba András, et al.
Publicado: (2017)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Systematic review of use of β-blockers in sepsis
por: Chacko, Cyril Jacob, et al.
Publicado: (2015)

Current Knowledge of Beta-Blockers in Chronic Hemodialysis Patients
por: Haddiya, Intissar, et al.
Publicado: (2023)

Renal Function and Death in Older Women: Which eGFR Formula Should We Use?
por: Canales, Muna T., et al.
Publicado: (2017)

Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010)

Increase use of β-blockers in patients with chronic obstructive pulmonary and cardiovascular disease
por: Yang, Yan-Li, et al.
Publicado: (2021)

The impact of COVID-19 on a large pragmatic clinical trial embedded in primary care
por: Leatherman, Sarah M., et al.
Publicado: (2023)

Association of Renin-Angiotensin System Blockers with Survival in Patients on Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
por: Luño, José, et al.
Publicado: (2017)

α-Blocker Use in Hemodialysis: The Japan Dialysis Outcomes and Practice Patterns Study
por: Iseri, Ken, et al.
Publicado: (2023)

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
por: Basile, Jan, et al.
Publicado: (2018)

Diuretic and β-Blocker in Hypertension—Then What?
por: Ramsay, L. E.
Publicado: (1980)

Efficacy of Patient Activation Interventions With or Without Financial Incentives to Promote Prescribing of Thiazides and Hypertension Control: A Randomized Clinical Trial
por: Kaboli, Peter J., et al.
Publicado: (2018)

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses
por: Baker, Jillian G., et al.
Publicado: (2011)

Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis
por: Yang, Yan-Li, et al.
Publicado: (2020)

Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis
por: Chen, Fu-An, et al.
Publicado: (2016)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Should β-blockers be used in septic shock?
por: Lira, Alena, et al.
Publicado: (2014)

Immunologic adverse reactions of β-blockers and the skin
por: Tatu, Alin Laurentiu, et al.
Publicado: (2019)

β-Blockers Improve Presinusoidal Portal Hypertension
por: Sørensen, Michael, et al.
Publicado: (2018)

β-blockers in septic shock: are we there yet?
por: Cruz, Madalena Coutinho, et al.
Publicado: (2017)

Progress in the Enantioseparation of β-Blockers by Chromatographic Methods
por: Yang, Yiwen, et al.
Publicado: (2021)

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
por: Ram, C Venkata S
Publicado: (2011)

Heart Rate and Cardiovascular Disease: An Alternative to Beta Blockers
por: Liang, Michael, et al.
Publicado: (2009)

Effectiveness of β-blockers in physically active patients with hypertension: protocol of a systematic review
por: Tučková, Dagmar, et al.
Publicado: (2016)

Polymorphism related to cardiovascular risk in hemodialysis subjects: a systematic review
por: Balbino, Karla Pereira, et al.
Publicado: (2018)

Cardio-selective versus non-selective β-blockers for cardiovascular events and mortality in long-term dialysis patients: A systematic review and meta-analysis
por: Tao, Shaohua, et al.
Publicado: (2022)

A comparison of hypotension and bradycardia following spinal anesthesia in patients on calcium channel blockers and β-blockers
por: Kaimar, Padmanabha, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6389f6rch2jto0dg0lvblkpp4m